Examination Report |
1 | TM-A(TRADE MARKS APPLICATION) | 04 Sep 2017 |
2 | Reply to Exam Report (MIS-R) | 25 Nov 2017 |
3 | TM-M(EXTENSION OF TIME) | 26 Mar 2019 |
4 | TM-M(REQUEST SUBMITTING AUTHORISATION OF AGENT) | 20 Jun 2019 |
5 | Journal Copy | 08 Jan 2020 |
6 | Certificate | 05 Mar 2020 |
1 | Hearing Notice (Show Cause) | 7769480 | 3845750 | 11 Feb 2019 |
2 | Hearing notice (Adjourned) | 8257968 | 4128859 | 14 May 2019 |
3 | Hearing notice (Adjourned) | 8674881 | 4328556 | 29 Jul 2019 |
4 | Hearing notice (Adjourned) | 8927167 | 4441479 | 16 Sep 2019 |
5 | Tribunal Accepted Notice for : 3626726 | 9083109 | 4462646 | 14 Oct 2019 |
Xitabin was applied on 04 September 2017.
Trademark application was filed by BIOLOGICAL E.
Trademark application has been filed under following classes.
5
As per IP India, trademark application is on the following stage:
Registered.
Listed application Id of Xitabin is 3626726.
Trademark attorney of the Xitabin is Kayser And Company.
Xitabin is a WORD as per IP India data.